Dexmedetomidine Versus Nalbuphine as an Adjuvant to Intrathecal Bupivacaine
Clinical trial NCT05347173 · COMPLETED
Trial details
- NCT number
- NCT05347173
- Sponsor
- Mansoura University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-21
- Primary completion
- 2024-01-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.